Acne can have a significant social and psychological impact, and early and appropriate treatment is key to reducing the risk of permanent scarring. Our Drug review provides a brief overview of clinical assessment and discusses the available treatment options, followed by sources of further information …
Articles: 25.19 5 October 2014
In our series on the history of prescribing policy, Dr Darrin Baines traces how successive governments have attempted to curb drug costs. Here, he describes the introduction of drug budgets and the renegotiation of the PPRS.
Drug budgets and the strengthening of the PPRS
The authors use national hospital prescribing data to examine the claim that hospitals are responsible for the inertia in moving away from NSAIDs with less favourable CV risk profiles.
Hospital initiated NSAIDs and reducing CV risk
Beta-blockers are widely prescribed in primary care for the management of cardiovascular disease. Beta-blockers are used in people with acute coronary syndrome and to prevent secondary coronary events. They also reduce death in people with chronic heart failure and are recommended first line for the …
Omega-3 fatty acid supplementation does not decrease the risk of cardiovascular outcomes in this older population. Although the numbers are small, supplementation may prevent heart disease in patients already at low risk; that is, patients without a history of cardiovascular disease and who are not …
Steve Chaplin and Dr Austin Leach provide an overview of the properties of transdermal fentanyl preparations in the management of severe chronic pain in adults and opioid-tolerant children.
Properties and use of transdermal fentanyl
Katy Mellor describes her role as a Macmillan clinical pharmacist within a community end-of-life team in Hull that provides palliative care to patients with complex needs.
The community Macmillan pharmacist project
The combination of varenicline (Champix) and nicotine replacement therapy is more effective than varenicline alone in achieving smoking abstinence at 12 weeks and 24 weeks in adult smokers.
Varenicline plus nicotine replacement therapy more effective than varenicline alone
Xigduo, a combination of dapagliflozin and metformin, is licensed as second-line therapy in patients with type 2 diabetes. In our New products review, Steve Chaplin presents the data relating to its efficacy and adverse events and Drs Claire McCourt and Frank Joseph discuss its place …